Predictive factors for recurrence include pathologic characteristics such as histologic type, tumor grade, lymphovascular invasion, and pathologic stage, alongside clinical parameters like age, sex, and serum carcinoembryonic antigen (CEA) levels [9–13]. This evidence concerns the gene CEACAM5 and neoplasm.